Week In Review: 3SBio Acquires Wansheng Pharma For $85 Million
July 25, 2015 at 16:00 PM EDT
3SBio of Shenyang acquired Zhejiang Wansheng Pharma, a small molecule drugmaker, for $85 million. Wansheng is approved to market 55 products in the areas of oncology, diabetes, cardiovascular and dermatology.
